Skip header and navigation

5 records – page 1 of 1.

Demystifying drug dosing in renal dysfunction

https://libcat.nshealth.ca/en/permalink/provcat44786
Branden D. Nemecek, Drayton A. Hammond (editors). --Bethesda, MD: American Society of Health-System Pharmacists , c2019.
Available Online
View e-Book
Location
Online
Chronic Kidney Disease affects approximately 10% of adults in the United States or approximately 20 million individuals. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. This new book addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction.
Available Online
View e-Book
Other Authors
Nemecek, Branden D.
Responsibility
Branden D. Nemecek, Drayton A. Hammond (editors)
Alternate Title
Drug dosing in renal dysfunction
Place of Publication
Bethesda, MD
Publisher
American Society of Health-System Pharmacists
Date of Publication
c2019
Physical Description
1 online resource, 294 p.
ISBN
9781585285518
Subjects (MeSH)
Drug Dosage Calculations
Kidney Diseases - drug therapy
Specialty
Nephrology
Pharmacology
Abstract
Chronic Kidney Disease affects approximately 10% of adults in the United States or approximately 20 million individuals. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. This new book addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction.
Format
e-Book
Location
Online
Less detail

Taking your medicines when you are sick: a guide for patients with chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams36519
Nova Scotia Health Authority. NSHA Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1340
Available Online
View Pamphlet
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSHA Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases
Abstract
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Notes
Previous title: Taking your Medicines when you are Ill - A Guide for Patients with Chronic Kidney Disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1340
Less detail

Tums (calcium carbonate) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. QEII. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1514
Available Online
View Pamphlet
Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamphlet explains why people with kidney disease need this medicine, how to take and store it, and a list of possible side effects. The French version of this pamphlet 2236, "Tums (carbonate de calcium) et maladies rénales," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Abstract
Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamphlet explains why people with kidney disease need this medicine, how to take and store it, and a list of possible side effects. The French version of this pamphlet 2236, "Tums (carbonate de calcium) et maladies rénales," is also available.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1514
Less detail

Tums (carbonate de calcium) et maladies rénales

https://libcat.nshealth.ca/en/permalink/chpams37499
Nova Scotia Health Authority. QEII. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2236
Available Online
View Pamphlet
Le médicament Tums (carbonate de calcium) permet de réguler le niveau de phosphore dans le corps. Ce dépliant explique pourquoi les personnes ayant des maladies rénales doivent prendre ce médicament, comment le prendre et le conserver, ainsi que ses effets secondaires possibles. ; This pamphlet is a French translation of the English pamphlet 1514, "Tums (Calcium Carbonate) and Kidney Disease". Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Renal Program
Alternate Title
Tums (calcium carbonate) and kidney disease
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Specialty
Nephrology
Abstract
Le médicament Tums (carbonate de calcium) permet de réguler le niveau de phosphore dans le corps. Ce dépliant explique pourquoi les personnes ayant des maladies rénales doivent prendre ce médicament, comment le prendre et le conserver, ainsi que ses effets secondaires possibles.
This pamphlet is a French translation of the English pamphlet 1514, "Tums (Calcium Carbonate) and Kidney Disease". Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamphlet explains why people with kidney disease need this medicine, how to take and store it, and a list of possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2236
Less detail

Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2307
Available Online
View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Subjects (LCSH)
Kidneys--Diseases--Treatment
Specialty
Nephrology
Medications
Abstract
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2307
Less detail